These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 11076532)

  • 21. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
    Townsend D; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
    Gackenheimer SL; Suter TM; Pintar JE; Quimby SJ; Wheeler WJ; Mitch CH; Gehlert DR; Statnick MA
    Neuropeptides; 2005 Dec; 39(6):559-67. PubMed ID: 16289278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis.
    Martin SS; Boucard AA; Clément M; Escher E; Leduc R; Guillemette G
    J Biol Chem; 2004 Dec; 279(49):51415-23. PubMed ID: 15452107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of opioid receptors in rat sensory neurons in culture.
    Chen JJ; Dymshitz J; Vasko MR
    Mol Pharmacol; 1997 Apr; 51(4):666-73. PubMed ID: 9106633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors.
    Sbrenna S; Marti M; Morari M; Calo G; Guerrini R; Beani L; Bianchi C
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1365-71. PubMed ID: 10565862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
    Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endomorphin-1 discriminates the mu-opioid receptor from the delta- and kappa-opioid receptors by recognizing the difference in multiple regions.
    Ide S; Sakano K; Seki T; Awamura S; Minami M; Satoh M
    Jpn J Pharmacol; 2000 Aug; 83(4):306-11. PubMed ID: 11001176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
    Ananthan S; Khare NK; Saini SK; Davis P; Dersch CM; Porreca F; Rothman RB
    Bioorg Med Chem; 2003 Sep; 11(18):4143-54. PubMed ID: 12927876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological profiles of selective non-peptidic delta opioid receptor ligands.
    Chaturvedi K; Jiang X; Christoffers KH; Chinen N; Bandari P; Raveglia LF; Ronzoni S; Dondio G; Howells RD
    Brain Res Mol Brain Res; 2000 Sep; 80(2):166-76. PubMed ID: 11038249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substituted cysteine accessibility of the third transmembrane domain of the creatine transporter: defining a transport pathway.
    Dodd JR; Christie DL
    J Biol Chem; 2005 Sep; 280(38):32649-54. PubMed ID: 16049011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor.
    Claude-Geppert PA; Liu J; Solberg J; Erickson-Herbrandson LJ; Loh HH; Law PY
    J Pharmacol Exp Ther; 2005 Apr; 313(1):216-26. PubMed ID: 15579496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.
    Holleran BJ; Domazet I; Beaulieu ME; Yan LP; Guillemette G; Lavigne P; Escher E; Leduc R
    Biochem Pharmacol; 2009 Apr; 77(8):1374-82. PubMed ID: 19426676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.
    Stein JA; Znamensky V; Baumer F; Rossi GC; Pasternak GW; Bodnar RJ
    Brain Res; 2000 May; 864(2):240-51. PubMed ID: 10802031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice.
    Javitch JA; Fu D; Chen J
    Biochemistry; 1995 Dec; 34(50):16433-9. PubMed ID: 8845371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor.
    Zhu J; Xue JC; Law PY; Claude PA; Luo LY; Yin J; Chen C; Liu-Chen LY
    FEBS Lett; 1996 Apr; 384(2):198-202. PubMed ID: 8612823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
    Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic nucleotide-gated channels. Pore topology studied through the accessibility of reporter cysteines.
    Becchetti A; Gamel K; Torre V
    J Gen Physiol; 1999 Sep; 114(3):377-92. PubMed ID: 10469728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat mu-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulation.
    Li J; Chen C; Huang P; Liu-Chen LY
    Mol Pharmacol; 2001 Nov; 60(5):1064-75. PubMed ID: 11641435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and gating changes of the sodium channel induced by mutation of a residue in the upper third of IVS6, creating an external access path for local anesthetics.
    Sunami A; Glaaser IW; Fozzard HA
    Mol Pharmacol; 2001 Apr; 59(4):684-91. PubMed ID: 11259611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the binding characteristics of the mu, delta and kappa subtypes of the opioid receptor in the hypothalamus of the normal cyclic ewe and in the ovariectomised ewe following treatment with ovarian steroids.
    Thom B; Canny BJ; Cowley M; Wright PJ; Clarke IJ
    J Endocrinol; 1996 Jun; 149(3):509-18. PubMed ID: 8691110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.